337 related articles for article (PubMed ID: 15773664)
41. Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis.
Voit T; Krogmann O; Lenard HG; Neuen-Jacob E; Wechsler W; Goebel HH; Rahlf G; Lindinger A; Nienaber C
Neuropediatrics; 1988 May; 19(2):62-71. PubMed ID: 3374765
[TBL] [Abstract][Full Text] [Related]
42. [Clinical significance of serum cardiac myosin light chain I in patients with muscular dystrophy].
Saitoh M; Miyakoda H; Kitamura H; Kasagi S; Takakura H
Rinsho Shinkeigaku; 1990 Aug; 30(8):835-9. PubMed ID: 2253417
[TBL] [Abstract][Full Text] [Related]
43. Trajectory of left ventricular ejection fraction in response to therapies in patients with muscular dystrophy.
Nikhanj A; Kashyap N; Wang K; Phan CL; Siddiqi ZA; Becher H; Oudit GY
Echocardiography; 2022 Oct; 39(10):1328-1337. PubMed ID: 36198087
[TBL] [Abstract][Full Text] [Related]
44. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
45. PGD for dystrophin gene deletions using fluorescence in situ hybridization.
Malmgren H; White I; Johansson S; Levkov L; Iwarsson E; Fridström M; Blennow E
Mol Hum Reprod; 2006 May; 12(5):353-6. PubMed ID: 16608904
[TBL] [Abstract][Full Text] [Related]
46. Respiratory function in the muscular dystrophies.
Rideau Y; Jankowski LW; Grellet J
Muscle Nerve; 1981; 4(2):155-64. PubMed ID: 7207506
[TBL] [Abstract][Full Text] [Related]
47. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria?
Kohli SK; Pantazis AA; Shah JS; Adeyemi B; Jackson G; McKenna WJ; Sharma S; Elliott PM
Eur Heart J; 2008 Jan; 29(1):89-95. PubMed ID: 17993472
[TBL] [Abstract][Full Text] [Related]
48. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
49. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
50. [Updates in muscular dystrophies].
Erazo-Torricelli R
Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
[TBL] [Abstract][Full Text] [Related]
51. Cardiac involvement in myotonic dystrophy, Becker muscular dystrophy and mitochondrial myopathy: a five-year follow-up.
Finsterer J; Stöllberger C; Blazek G; Spahits E
Can J Cardiol; 2001 Oct; 17(10):1061-9. PubMed ID: 11694896
[TBL] [Abstract][Full Text] [Related]
52. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure.
Aras D; Tufekcioglu O; Ergun K; Ozeke O; Yildiz A; Topaloglu S; Deveci B; Sahin O; Kisacik HL; Korkmaz S
J Card Fail; 2006 Dec; 12(9):726-33. PubMed ID: 17174235
[TBL] [Abstract][Full Text] [Related]
53. Muscular dystrophies and other genetic myopathies.
Shieh PB
Neurol Clin; 2013 Nov; 31(4):1009-29. PubMed ID: 24176421
[TBL] [Abstract][Full Text] [Related]
54. Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients.
Matsumura T; Saito T; Fujimura H; Shinno S
Brain Dev; 2007 Sep; 29(8):496-501. PubMed ID: 17376624
[TBL] [Abstract][Full Text] [Related]
55. Hypogonadism is common in men with myopathies.
Al-Harbi TM; Bainbridge LJ; McQueen MJ; Tarnopolsky MA
J Clin Neuromuscul Dis; 2008 Jun; 9(4):397-401. PubMed ID: 18525423
[TBL] [Abstract][Full Text] [Related]
56. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.
Bhakta D; Lowe MR; Groh WJ
Am Heart J; 2004 Feb; 147(2):224-7. PubMed ID: 14760317
[TBL] [Abstract][Full Text] [Related]
58. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
59. Cardiac involvement in Becker muscular dystrophy.
Melacini P; Fanin M; Danieli GA; Fasoli G; Villanova C; Angelini C; Vitiello L; Miorelli M; Buja GF; Mostacciuolo ML
J Am Coll Cardiol; 1993 Dec; 22(7):1927-34. PubMed ID: 8245351
[TBL] [Abstract][Full Text] [Related]
60. FSHD-like patients without 4q35 deletion.
Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
